Nuvalent (NUVL) Net Equity Issued and Repurchased (2020 - 2026)

Nuvalent (NUVL) posted Net Equity Issued and Repurchased of $10.1 million for Q1 2026, down 97.98% on a QoQ basis from $500.6 million in Q4 2025, and up 122.55% year-over-year from $4.6 million in Q1 2025.

Nuvalent (NUVL) Net Equity Issued and Repurchased (2020 - 2026) Analysis & Trends

Nuvalent's Net Equity Issued and Repurchased history runs 6 years deep, the most recent figure standing at $10.1 million for Q1 2026.

  • Quarterly Net Equity Issued and Repurchased rose 122.55% year-over-year to $10.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $521.3 million (down 6.52% YoY) and the FY2025 annual result came in at $515.7 million, down 9.52% from the prior year.
  • Net Equity Issued and Repurchased was $10.1 million for Q1 2026 at Nuvalent, down from $500.6 million in the prior quarter.
  • Across five years, Net Equity Issued and Repurchased topped out at $540.0 million in Q3 2024 and bottomed at $619000.0 in Q1 2023.
  • A 4-year average of $109.5 million and a median of $5.8 million in 2025 frame the typical range for Net Equity Issued and Repurchased.
  • Annual changes were most pronounced in 2024 — Net Equity Issued and Repurchased soared 38804.9% — and 2025, when it tumbled 99.12%.
  • Nuvalent's Net Equity Issued and Repurchased stood at $334.8 million in 2023, then slumped by 97.38% to $8.8 million in 2024, then surged by 5597.51% to $500.6 million in 2025, then tumbled by 97.98% to $10.1 million in 2026.
  • Business Quant data shows NUVL's Net Equity Issued and Repurchased at $10.1 million in Q1 2026, $500.6 million in Q4 2025, and $4.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 163.10 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 141.90 Mn
10 Nuvalent 9.75 Bn 9.75 Bn - 10.14 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 10.14 Mn
Mar 31, 2026 10.14 Mn
Dec 31, 2025 500.64 Mn
Dec 31, 2025 500.64 Mn
Sep 30, 2025 4.77 Mn
Sep 30, 2025 4.77 Mn
Jun 30, 2025 5.76 Mn
Jun 30, 2025 5.76 Mn
Mar 31, 2025 4.55 Mn
Mar 31, 2025 4.55 Mn
Dec 31, 2024 8.79 Mn
Dec 31, 2024 8.79 Mn
Sep 30, 2024 540.00 Mn
Sep 30, 2024 540.00 Mn
Jun 30, 2024 4.29 Mn
Jun 30, 2024 4.29 Mn
Mar 31, 2024 6.45 Mn
Mar 31, 2024 6.45 Mn
Dec 31, 2023 334.81 Mn
Dec 31, 2023 334.81 Mn